Back
Arrowhead Pharmaceuticals Stock Price Chart
Sponsored
ARWR
Sponsored
Free 23-page book shares my #1 indicator to use
Here's the 23-page free book.
Sell
20
ARWR
Arrowhead Pharmaceuticals
Last Price:
21.14
Seasonality Move:
6.36%
7 Day Trial
ALL ACCESS PASS
$
7
"The Next Apple?" - Mode's Growth Story is Turning Heads
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARWR is experiencing slight buying pressure.
Arrowhead Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.89 | Sell |
20-day SMA: | 22.72 | Sell |
50-day SMA: | 24.98 | Sell |
200-day SMA: | 27.23 | Sell |
8-day EMA: | 21.06 | Sell |
20-day EMA: | 22.26 | Sell |
50-day EMA: | 23.83 | Sell |
200-day EMA: | 26.5 | Sell |
Arrowhead Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.2 | Sell |
Relative Strength Index (14 RSI): | 38.46 | Sell |
Chaikin Money Flow: | 358727 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (21.28 - 24.28) | Sell |
Bollinger Bands (100): | (22.65 - 26.99) | Sell |
Arrowhead Pharmaceuticals Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Arrowhead Pharmaceuticals Stock
Is Arrowhead Pharmaceuticals Stock a Buy?
- Arrowhead Pharmaceuticals share price is 20.78 while ARWR 8-day simple moving average is 20.89, which is a Sell signal.
- The stock price of ARWR is 20.78 while Arrowhead Pharmaceuticals 20-day SMA is 22.72, which makes it a Sell.
- Arrowhead Pharmaceuticals 50-day simple moving average is 24.98 while ARWR share price is 20.78, making it a Sell technically.
- ARWR stock price is 20.78 and Arrowhead Pharmaceuticals 200-day simple moving average is 27.23, creating a Sell signal.
ARWR Technical Analysis vs Fundamental Analysis
Sell
20
Arrowhead Pharmaceuticals (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals a Buy or a Sell?
-
Arrowhead Pharmaceuticals stock is rated a Sell
The current Arrowhead Pharmaceuticals [ARWR] share price is $20.78. The Score for ARWR is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Arrowhead Pharmaceuticals Stock Info
Market Cap:
2.58B
Price in USD:
20.78
Share Volume:
1.37M
Arrowhead Pharmaceuticals 52-Week Range
52-Week High:
39.83
52-Week Low:
19.44
Sell
20
Arrowhead Pharmaceuticals (ARWR)
is a Sell
Arrowhead Pharmaceuticals Share Price Forecast
-
What is the Arrowhead Pharmaceuticals stock price today?
The Arrowhead Pharmaceuticals stock price is 20.78 USD today. -
Will ARWR stock go up or go down?
Arrowhead Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Arrowhead Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Arrowhead Pharmaceuticals is overvalued.
Is Arrowhead Pharmaceuticals Stock a Buy?
- Arrowhead Pharmaceuticals share price is 20.78 while ARWR 8-day exponential moving average is 21.06, which is a Sell signal.
- The stock price of ARWR is 20.78 while Arrowhead Pharmaceuticals 20-day EMA is 22.26, which makes it a Sell.
- Arrowhead Pharmaceuticals 50-day exponential moving average is 23.83 while ARWR share price is 20.78, making it a Sell technically.
- ARWR stock price is 20.78 and Arrowhead Pharmaceuticals 200-day simple moving average is 26.50, creating a Sell signal.
Fundamental Analysis of Arrowhead Pharmaceuticals
Is Arrowhead Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.51 per share, an increase next quarter of $0.05 per share, a decrease this year of $3.09 per share, and an increase next year of $0.08 per share.
Technical Analysis of Arrowhead Pharmaceuticals
Should I short Arrowhead Pharmaceuticals stock?
- ARWR Moving Average Covergence Divergence (MACD) indicator is -1.2, suggesting Arrowhead Pharmaceuticals is a Sell
- Arrowhead Pharmaceuticals Relative Strength Index (RSI) is 38.46, which suggest Arrowhead Pharmaceuticals is oversold
- The Bollinger Bands (25) for Arrowhead Pharmaceuticals is (21.28 - 24.28), which suggest Arrowhead Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Arrowhead Pharmaceuticals is (22.65 - 26.99), which suggest Arrowhead Pharmaceuticals is a Sell
* Arrowhead Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.